| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/1999 | EP0923552A1 Pyranoindole and carbazole inhibitors of cox-2 |
| 06/23/1999 | EP0923551A1 4-aminoethoxy indolone derivatives |
| 06/23/1999 | EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 06/23/1999 | EP0923549A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use |
| 06/23/1999 | EP0923548A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a? ligands |
| 06/23/1999 | EP0923547A1 Bidentate metalloprotease inhibitors |
| 06/23/1999 | EP0923546A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 06/23/1999 | EP0923545A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| 06/23/1999 | EP0923543A1 Potassium channel inhibitors |
| 06/23/1999 | EP0923542A1 Aryl substituted cyclic amines as selective dopamine d3 ligands |
| 06/23/1999 | EP0923539A1 Compounds with growth hormone releasing properties |
| 06/23/1999 | EP0923538A1 Compounds which can form complexes with metals |
| 06/23/1999 | EP0923536A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 06/23/1999 | EP0923535A1 Inhibitors of cysteine protease |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 06/23/1999 | EP0923399A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 06/23/1999 | EP0923382A1 Compositions of plant carbohydrates as dietary supplements |
| 06/23/1999 | EP0923381A1 Method to obtain oestrogens from mare's urine |
| 06/23/1999 | EP0923380A1 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation |
| 06/23/1999 | EP0923379A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 06/23/1999 | EP0923378A1 Promotion of wound healing by chemically-modified tetracyclines |
| 06/23/1999 | EP0923377A1 Therapeutic uses for an aminosterol compound |
| 06/23/1999 | EP0923376A1 Treatment of asthma and airway diseases |
| 06/23/1999 | EP0923375A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl heterocyclic compound |
| 06/23/1999 | EP0923374A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-trihexyphenidyl |
| 06/23/1999 | EP0923373A1 Il-8 receptor antagonists |
| 06/23/1999 | EP0923372A1 Pyridinone thrombin inhibitors |
| 06/23/1999 | EP0923371A1 Pharmaceutical compositions comprising tyrphostins |
| 06/23/1999 | EP0923370A2 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 06/23/1999 | EP0923369A1 1-o-alkylglycerols for pharmaceutical or veterinary use for preserving and/or improving sperm |
| 06/23/1999 | EP0923366A1 Sunscreen compositions containing damaged rna fragments |
| 06/23/1999 | EP0923292A1 Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals |
| 06/23/1999 | EP0923287A1 Nonclassical pyrrolo 2,3-d]pyrimidine antifolates |
| 06/23/1999 | EP0814660B1 Topical antimicrobial agents |
| 06/23/1999 | EP0752861A4 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 06/23/1999 | EP0671915B1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development |
| 06/23/1999 | EP0639186B1 Taxol derivatives |
| 06/23/1999 | EP0636024B1 Potentiation of antimicrobial effects |
| 06/23/1999 | EP0565668B1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
| 06/23/1999 | EP0502117B1 Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |
| 06/23/1999 | CN1220667A Morphinane derivatives and medicinal use thereof |
| 06/23/1999 | CN1220660A Alkyloxyamino substituted fluorenones and their use as protein kinase cinhibitors |
| 06/23/1999 | CN1220658A Galcium receptor-active compound |
| 06/23/1999 | CN1220656A Novel trienoic retinoid compounds and method |
| 06/23/1999 | CN1220609A Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/23/1999 | CN1220606A P1, P4-dithio-P2,P3-monochloromethylene 5',5'-diadenosine P1,P4-tetraphosphate as antithrombotic agent |
| 06/23/1999 | CN1220605A Nucleotide analogues for topical treatment of proliferative disease of skin |
| 06/23/1999 | CN1220604A Anti-HIV composition containing imidazole derivative |
| 06/23/1999 | CN1220603A Anti-viral compounds |
| 06/23/1999 | CN1220602A Anti-viral compounds |
| 06/23/1999 | CN1220601A Anti-viral compounds |
| 06/23/1999 | CN1220600A Tetrahydrolipstatin-containing compositions |
| 06/23/1999 | CN1220599A Use of 2-(3,4-dimethoxycinnamoyl) aminobenzoic acid for manufacture of medicament for treatment or prevention of restenosis |
| 06/23/1999 | CN1220598A Suspension of spraingly water-soluble acidic drug |
| 06/23/1999 | CN1220583A Improvements in or relating to compositions containing creatine |
| 06/23/1999 | CN1220269A Microphyllous hypericum total glycoside and its preparation process |
| 06/23/1999 | CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof |
| 06/23/1999 | CN1220265A New piperazine and piperidine compounds |
| 06/23/1999 | CN1220263A Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 06/23/1999 | CN1220262A 7-phenyl-1,4-stable derivative, its preparing method and medicine containing said compound |
| 06/23/1999 | CN1220260A Acorus calamus extracts in Acorus gramineus and their use |
| 06/23/1999 | CN1220257A Method for preparation of hypotensor-laminine |
| 06/23/1999 | CN1043786C Method for preparing antibiotic compound |
| 06/23/1999 | CN1043769C L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus and its use |
| 06/23/1999 | CN1043768C Avermectin derivative, its preparing method and use, and drug composition containing said derivative |
| 06/23/1999 | CN1043766C Indole derivative and preparation and pharmaceutical using of same |
| 06/23/1999 | CN1043765C Pyrroloquinolinone derivatives, its preparing method, its intermediate and drug composition containing the same |
| 06/23/1999 | CN1043764C Bicycle carboxamides as 5-HT1A antagonists |
| 06/23/1999 | CN1043763C Tropane-aldoxine derivatives and preparation process and use thereof |
| 06/23/1999 | CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition |
| 06/23/1999 | CN1043761C Fluorinated hydroxyalkylquinoline acid and medicinal salt and its drug composition |
| 06/23/1999 | CN1043760C Pyridinecarboximidamide and its acid addition salt and its drug composition |
| 06/23/1999 | CN1043759C Process for preparation of 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| 06/23/1999 | CN1043731C Nitrendipine adhesive plaster for curing hypertension and preparing method thereof |
| 06/22/1999 | US5914425 Modifications of 2-amino-4-(4-5fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation |
| 06/22/1999 | US5914411 Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position |
| 06/22/1999 | US5914406 Azepanes and their ring homologues having protein kinase inhibiting activity |
| 06/22/1999 | US5914402 Process for preparing 1-aryl-4-oxopyrrolo 3,2-c! quinoline derivatives |
| 06/22/1999 | US5914400 Method and compositions for the synthesis of BCH-189 and related compounds |
| 06/22/1999 | US5914352 Methods for the use of stabilized fluorocarbon emulsions |
| 06/22/1999 | US5914350 Pharmaceutical compositions of nitro- and aminobenzamide compounds for neurodegenerative disorders |
| 06/22/1999 | US5914349 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 06/22/1999 | US5914347 By adding to a hydroxyalkyl cellulose, evaporating the solution or dispersion to dryness under an inert atmosphere to prepare a powder; imparts oxidation resistance |
| 06/22/1999 | US5914346 Using conjugated linoleic acid |
| 06/22/1999 | US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins |
| 06/22/1999 | US5914342 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists |
| 06/22/1999 | US5914341 Anticarcinogenic agents and enzyme inhibitors |
| 06/22/1999 | US5914340 Leukotriene antagonists useful for treating dermatoses |
| 06/22/1999 | US5914338 Heterocyclic compounds and their preparation and use |
| 06/22/1999 | US5914337 Compounds and pharmaceutical compositions thereof for eliciting analgesic effects |
| 06/22/1999 | US5914336 Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
| 06/22/1999 | US5914334 Stable gel formulation for topical treatment of skin conditions |
| 06/22/1999 | US5914333 Treatment of psychotic disorders |
| 06/22/1999 | US5914332 Retroviral protease inhibiting compounds |
| 06/22/1999 | US5914330 Administering an imidazole-containing pyrimidine derivative effective to protect against renal failure without reducing blood pressure |
| 06/22/1999 | US5914329 Dimesylate salts of neuropeptide Y ligands |